Ownership

Murat Kalayoglu - Insider Trading & Ownership

Entity: Individual
Location: C/O Cartesian Therapeutics, Inc., 704 Quince Orchard Rd, Gaithersburg, MD
Summary: The estimated net worth of Murat Kalayoglu is at least $16.7M dollars as of January 6, 2025. Murat Kalayoglu is the Director, 10%+ Owner of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $16.7M.
All Insider Reports: All Insider Reports

Ownership of Murat Kalayoglu

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RNAC	Cartesian Therapeutics, Inc.	Director, 10%+ Owner	$16.7M			Jan 2, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Murat Kalayoglu:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
RNAC	Cartesian Therapeutics, Inc.	Common Stock	Award	+0.51%	$0	0.00	+2.6K	509K	1/2/2025	Direct
RNAC	Cartesian Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+7.8K	7.8K	1/2/2025	Direct
RNAC	Cartesian Therapeutics, Inc.	Common Stock	Options Exercise	+50%	$0		+1.52M	4.56M	10/11/2024	by trust
RNAC	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Options Exercise	-44.7%	$0		-45.6K	56.4K	10/11/2024	by trust
RNAC	Cartesian Therapeutics, Inc.	Common Stock	Options Exercise	+2657.7%	$0		+2.93M	3.04M	4/8/2024	by trust
RNAC	Cartesian Therapeutics, Inc.	Common Stock	Options Exercise	+3386.5%	$0		+492K	506K	4/8/2024	Direct
RNAC	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Options Exercise	-46.3%	$0		-87.8K	102K	4/8/2024	by trust
RNAC	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Options Exercise	-100%	$0		-14.8K	0	4/8/2024	Direct
RNAC	Cartesian Therapeutics, Inc.	Common Stock	Award	+69.1%	$0	0.00	+178K	436K	1/2/2024	Direct
RNAC	Cartesian Therapeutics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+228K	228K	1/2/2024	Direct
SELB	Cartesian Therapeutics, Inc.	Common Stock	Award		$0	0.00	+258K	258K	11/13/2023	Direct
SELB	Cartesian Therapeutics, Inc.	Common Stock	Other		$0	0.00	+3.3M	3.3M	11/13/2023	by trust
SELB	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Award		$0		+14.8K	14.8K	11/13/2023	Direct
SELB	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Other		$0		+189K	189K	11/13/2023	by trust
SELB	Cartesian Therapeutics, Inc.	Series A Non-Voting Convertible Preferred Stock	Purchase		$155M	249,999.98^*	+620	620	11/13/2023	by trust

Showing 1 to 15 of 15 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.